NCT00666029View on ClinicalTrials.gov

Implications for Treatment of the Metabolic Syndrome

PHASE2CompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

February 28, 2006

Primary Completion Date

February 29, 2008

Study Completion Date

February 29, 2008

Conditions
Metabolic Syndrome
Interventions
DRUG

atorvastatin

40 m.g. o.d. tablets for 6 months

DRUG

placebo

Placebo

All Listed Sponsors
lead

University Hospital Southampton NHS Foundation Trust

OTHER

NCT00666029 - Implications for Treatment of the Metabolic Syndrome | Biotech Hunter | Biotech Hunter